Cytosorbents
CTSO
#9825
Rank
โ‚ฌ39.38 M
Marketcap
0,63ย โ‚ฌ
Share price
-1.20%
Change (1 day)
-27.19%
Change (1 year)

Revenue for Cytosorbents (CTSO)

Revenue in 2025 (TTM): โ‚ฌ32.75 Million

According to Cytosorbents's latest financial reports the company's current revenue (TTM ) is โ‚ฌ31.01 Million. In 2024 the company made a revenue of โ‚ฌ34.2 Million an increase over the revenue in the year 2023 that were of โ‚ฌ28.11 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytosorbents from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ32.75 M-4.25%
2024 โ‚ฌ34.2 M21.64%
2023 โ‚ฌ28.11 M2.74%
2022 โ‚ฌ27.37 M-22.72%
2021 โ‚ฌ35.41 M10.41%
2020 โ‚ฌ32.07 M57.83%
2019 โ‚ฌ20.32 M14.8%
2018 โ‚ฌ17.7 M58.73%
2017 โ‚ฌ11.15 M42.96%
2016 โ‚ฌ7.8 M110.32%
2015 โ‚ฌ3.7 M43.46%
2014 โ‚ฌ2.58 M334.5%
2013 โ‚ฌ0.59 M-250.38%
2012 -โ‚ฌ0.4 Million-1524.36%
2011 โ‚ฌ0.02 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Meridian Bioscience
VIVO
โ‚ฌ0.28 B 822.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ3.46 B 11,085.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚ฌ16.61 B 53,490.05%๐Ÿ‡บ๐Ÿ‡ธ USA